ASCO Immunotherapy Roundup - 2: Chugai Has High Hopes for Atezolizumab Combos with Group Portfolios

July 14, 2015
Asami Morioka, Medical Manager, Medical Science Department at the Medical Affairs Division, Chugai Swiss oncology powerhouse Roche is developing the anti-PD-1 antibody atezolizumab. In the second of this series, we spoke with development officials from its group company, Chugai Pharmaceutical,...read more